Applications: | Immunodepletion/Immunocompetition |
Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description : | Cannabinoid Receptor II Blocking Peptide is synthetically produced from the 300-347 sequence and is suitable for use in western blot applications. |
Formulation: | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
Storage Instruction: | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
Gene Symbol: | Cnr2 |
Gene ID: | 12802 |
Uniprot ID: | CNR2_MOUSE |
Immunogen Region: | 300-347 |
Immunogen: | Synthetic peptide taken within amino acid region 300-347 on mouse CB2 Receptor protein common to both CB2L and CB2S. |
Tissue Specificity | Expressed by cells of hematopoietic origin. Expressed in skin in suprabasal layers and hair follicles, in brain by neurons and glial cells and by osteoblasts, osteocytes, osteoclasts (at protein level). |
Function | Heterotrimeric G protein-coupled receptor for endocannabinoid 2-arachidonoylglycerol mediating inhibition of adenylate cyclase. May function in inflammatory response, nociceptive transmission and bone homeostasis. |
Peptide Name | Cannabinoid Receptor 2Cb-2Cb2Mcb2 |
Database Links | Reactome: R-MMU-373076Reactome: -MMU-418594 |
Cellular Localisation | Cell MembraneMulti-Pass Membrane ProteinCell ProjectionDendritePerikaryonLocalizes To Apical Dendrite Of Pyramidal Neurons |
Alternative Peptide Names | Cannabinoid Receptor 2 proteinCb-2 proteinCb2 proteinMcb2 proteinCnr2 protein |
Information sourced from Uniprot.org